Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Valeric Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103290078A details enzymatic production of 5-aminovaleric acid. Offers high purity, simplified purification, and scalable bio-based manufacturing solutions.
Patent CN106905137A details a high-yield valeric acid synthesis from biomass. Discover cost-effective, eco-friendly manufacturing solutions for global supply chains.
Patent CN103373914B reveals a breakthrough in hydroxy acid manufacturing using TS-1 catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel ruthenium-catalyzed asymmetric hydrogenation process for high-purity valeric acid derivatives. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN106191151B reveals a novel biotransformation route for high-purity D-lysine and 5-aminovaleric acid co-production, offering significant supply chain and cost advantages for global manufacturers.
Patent CN1065522C details a novel rhodium-catalyzed hydroformylation process for 5-formylvalerate esters, offering superior selectivity and simplified ligand synthesis for industrial applications.
Patent CN103290078B reveals purified enzyme catalysis for 5-aminovaleric acid production offering simplified separation and high yield for scalable polymer intermediate manufacturing supply chains.
Novel synthetic method for 2,5-dihydroxyvaleric acid delta lactone intermediates offering cost reduction and scalable production for pharmaceutical applications globally.
Novel biomass-derived route for polyamide intermediates. Reduces energy and waste via catalytic hydroformylation and carbonylation technology.
Patent CN116143586B details a safer route for valproate impurity synthesis, offering cost reduction and scalable supply chain solutions for global manufacturers.
Patent CN116947600B reveals atom-economic synthesis for valproic acid impurity control. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN110358752A reveals enzymatic route for high-purity Brivaracetam intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110343056A reveals a cost-effective three-step synthesis route. This method ensures high purity and supply chain reliability for pharmaceutical intermediates.
Patent CN106191089B accelerates 5-AVA yield via transporter overexpression, offering cost-effective supply chain solutions for global pharmaceutical and chemical manufacturers.
Patent CN117209374A reveals copper-catalyzed CO2 fixation for chiral quaternary centers. Offers cost reduction and scalable supply chain solutions for fine chemical manufacturing.